CT1812
Drug timelines are a Plus or Pro feature.
9 regulatory and trial events tracked for CT1812, covering 2016-09-07 to 2026-03-12. Get the full timeline:
Most recent: Clinical Trial Update: Study to Evaluate the Safety, Tolerability and Efficacy of CT1812 in Subjects With Mild to Moderate Dementia With Lewy Bodies [Phase 2]